carnitine has been researched along with Hyperchylomicronemia Late Onset in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"L-Carnitine has been reported to reduce Lp(a) levels." | 2.84 | L-Carnitine/Simvastatin Reduces Lipoprotein (a) Levels Compared with Simvastatin Monotherapy: A Randomized Double-Blind Placebo-Controlled Study. ( Bilianou, E; Elisaf, MS; Florentin, M; Liberopoulos, EN; Nikolaou, V; Pitsavos, C; Rizos, CV, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Florentin, M | 1 |
Elisaf, MS | 1 |
Rizos, CV | 1 |
Nikolaou, V | 1 |
Bilianou, E | 1 |
Pitsavos, C | 1 |
Liberopoulos, EN | 1 |
1 trial available for carnitine and Hyperchylomicronemia Late Onset
Article | Year |
---|---|
L-Carnitine/Simvastatin Reduces Lipoprotein (a) Levels Compared with Simvastatin Monotherapy: A Randomized Double-Blind Placebo-Controlled Study.
Topics: Adult; Apolipoprotein B-100; Cardiovascular Diseases; Carnitine; Cholesterol; Double-Blind Method; D | 2017 |